NAOV רווח לאחר מס NanoVibronix Inc.

The profit trajectory of NanoVibronix, Inc. demonstrates current operational efficiency, where the -0.01 mark characterizes this parameter. Current cash flows of NanoVibronix, Inc. consistently cover expenses. Demand for ultrasound therapy remains largely independent of economic cycles and seasonality. Furthermore, the implementation of reusable sensors reduces medical waste, supporting ESG environmental standards.

Comparative asset analysis requires an assessment of net income as the final residual income after deducting all operating and financial expenses, which determines the issuer's actual investment attractiveness. This financial and operational result for NanoVibronix, Inc. (NAOV) reflects the effectiveness of ESG standard implementation and the optimization of eco-design costs, allowing investors to evaluate the business model's resilience to macroeconomic fluctuations.